Kate Cygnar

Kate Cygnar

Company: Regeneron Pharmaceuticals

Job title: Associate Director - Genome Engineering Technologies


Cell-Type Selective Targeted Delivery of a Recombinant Lysosomal Enzyme for Enzyme Therapies 4:00 pm

Antibodies or antibody fragments can be linked to lysosome enzymes to improve delivery to tissues and cell types of interest Such molecules can be delivered as a purified protein, or via gene therapy delivery methods Pre-clinical data for antibody-lysosomal alpha glucosidase (GAA) fusion proteins under study for Pompe disease will be discussedRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.